Expert perspectives on prostate cancer with deference to clinical presentations, diagnosis, and prognosis.
International Panel Forms Consensus Best Practices for Active Surveillance in Prostate Cancer
Health care expert and lived experience panels came to a consensus on several aspects that should be considered in the decision to offer and continue active surveillance for prostate cancer.
Read More
CRISPR Knockout Identifies New Biomarkers for PARP Inhibitor Resistance in Prostate Cancer
The report also suggests that ataxia telangiectasia and Rad3-related protein inhibition could be a valuable tool to overcome resistance.
Route Does Not Impact Diagnostic Accuracy of Micro-Ultrasound Targeted Prostate Biopsies, Study Finds
The report suggests that high-resolution micro-ultrasound could help identify clinically significant lesions that would be missed with conventional MRI.
Risk Prediction for Risk Mitigation in Prostate Cancer Explored in New Study
The importance of identifying rare pathogenic mutations and genetic risk score among patients was explored in this new analysis, with goals that included reducing mortality and early disease detection.
Social Determinants of Health Linked With Varying Prostate Cancer Outcomes by Race
A meta-analysis supported that Black men have similar or better prostate cancer outcomes compared with White men when health care access is equal and treatment is standardized for all patients.
Latest ACS Cancer Statistics Report Highlights Alarming Trends, Disparities in Prostate Cancer
Following the release of its 2023 report on cancer statistics, the American Cancer Society announced a new initiative to improve prostate cancer outcomes and reduce disparities.